ArticleApplied biochemistry and biotechnology2026
Therapeutic Potential and Toxicological Impact of Graphene Quantum Dot Nanocomposites in Adult Zebra Fish.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fabricated graphene quantum dots (FQD) are popularly used in biomedical applications, as well as for biosensing, drug administration, and anticancer therapy. Despite the promising biomedical applications of graphene quantum dots, their long-term biocompatibility and toxicological safety remain insufficiently understood. Therefore, this study aimed to develop a bioenhanced FQD nanocomposite and evaluate its biocompatibility, wound healing potential, and toxicity using in vitro endothelial cells and adult zebrafish models. In silico molecular docking confirmed favourable binding to the wound healing target protein (-3.526 kcal/mol), supporting the therapeutic potential of FQDs. The toxicity and safety of employing these materials, however, must be further evaluated due to their unfavourable side effects. The primary goal of the current investigation was to examine in adult Zebrafish (Danio rerio) the toxicities and wound-healing capacity of FQD. Cytotoxicity and scratch wound migratory assay demonstrated significant result with the concentration of 5 µg/ ml. The live model was exposed to different sample concentrations ranging from 1 to 25 µg/mL for the evaluation period of 14 days to examine the samples chronic effects. The acute toxicity in vital organs was examined and the result demonstrates defined morphology of cardiomyocytes, normal distribution of hepatocytes, densely packed parenchymal architecture of pancreatic artery and uniformly distributed neuronal cells. Up to the concentration of 5 µg results were closer to control groups with nil mortality. The end of 48 h observation concentration dependent efficacy was observed closer to control groups for exhibiting excellent wound healing percentage.
Indexed as
Identifiers
42667536What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.